UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Bionx Implants, Inc.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 22-3458598
- --------------------------------------------------------------------------------
(State of incorporation or organization) (I.R.S. Employer Identification No.)
279B Great Valley Parkway, Malvern, Pennsylvania 19355
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class Name of each exchange on which
to be so registered each class is to be registered
- --------------------------------------------------------------------------------
-------------------------------------------------------------------------------
If this Form relates to the registration of a class of debt securities
and is effective upon filing pursuant to General Instruction A.(c)(1), please
check the following box. [ ]
If this Form relates to the registration of a class of debt securities
and is to become effective simultaneously with the effectiveness of a concurrent
registration statement under the Securities Act of 1933 pursuant to General
Instruction A.(c)(2), please check the following box. [ ]
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, par value $.0019 per share
- --------------------------------------------------------------------------------
(Title of class)
- --------------------------------------------------------------------------------
(Title of class)
<PAGE>
- --------------------------------------------------------------------------------
Item 1. Description of Registrant's Securities to be Registered.
The description of the Common Stock, par value $.0019 per share (the
"Common Stock"), of Bionx Implants, Inc. (the "Company") set forth under the
caption "Description of Capital Stock" in the Company's Registration Statement
on Form S-1, File No. 333-22359 (the "Registration Statement") filed with the
Securities and Exchange Commission (the "Commission") is incorporated herein by
reference. In addition, the description of the Common Stock set forth under the
caption "Description of Capital Stock" in any amendment to the Registration
Statement filed with the Commission by the Company or in any prospectus relating
to the Registration Statement filed with the Commission by the Company pursuant
to Rule 424(b) promulgated under the Securities Act of 1933, as amended, shall
be deemed to be incorporated herein by reference.
Item 2. Exhibits.
3.1 Restated Certificate of Incorporation of the Registrant as
currently in effect.*
3.2 Form of Restated Certificate of Incorporation to be filed after
the closing of the offering made under the Registration Statement.*
3.3 By-laws of the Registrant.*
4.1 Form of stock certificate evidencing ownership of Common Stock.*
* Incorporated by reference to the identically numbered Exhibit to the
Company's Registration Statement on Form S-1, File No. 333-22359.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereto duly authorized.
Registrant: BIONX IMPLANTS, INC.
----------------------------------------
Date: April 18, 1997
By: /s/ David W. Anderson
______________________________________
David W. Anderson
President and Chief Executive Officer
